1999•Journal of Allergy and Clinical ImmunologyOpen access

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★

Marianne van Hage-Hamsten, Marianne Kronqvist, OLLE ZETTERSTRÖM, Eva Johansson, Verena Niederberger, Susanne Vrtala, Hans Grönlund, Reidar Grönneberg, Rudolf Valenta

Open full text 93 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 93 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Hypoallergenic, Recombinant DNA, Allergen, Pollen, Chemistry, Biology, Botany, Biochemistry

Back to paper search Browse research topics Original source

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★ — Research Paper | ScholarLens